Clinical research of effectiveness and economic feasibility of Chuna manual therapy for temporomandibular disorder: A multicenter randomized controlled trial

Kyung Hee University0 个研究点目标入组 80 人开始时间: 待定最近更新: 2020年4月21日

试验速览

At the primary end point (5 week), VAS for TMD pain improved significantly in both group. But there was no significant difference between 2 groups. By the RM ANOVA, there was no significant difference in the change of VAS over time between 2 groups. 2. NRS for pain, NRS for bothersomeness of the TMD, and BDI score improved significantly in both groups, but there was no significant difference between 2 groups. JFLS improved significantly only in the CMT group.

•1) Temporomandibular joint pain on one or both sides
•2) Temporomandibular joint pain intensity NRS(Numeral Rating Scale) = 4
•3) sustained temporomandibular joint pain for more than 3 months
•4) Patients diagnosed with myofascial temporomandibular joint disorders(Axis I: Group 1) in the RDC/TMD diagnostic criteria
•* RDC/TMD(Research Diagnostic Criteria for temporomandibular joint disorders)
•5) Informed consent for study participation
•6) Men or women aged between 19 and 70 years

•1) Temporomandibular Joint pain induced by traffic accident or traumatic injury
•2) excluded in myofascial temporomandibular joint disorders(Axis I: Group 1) based on the RDC/TMD diagnostic criteria
•* RDC/TMD(Research Diagnostic Criteria for Temporomandibular Disorders)
•3) paticipants after surgery with temporomandibular joint disorders
•4) other diseases (e.g., rheumatoid arthritis, tumor, stroke and myocardial infarction) that may interfere with the interpretation of the results.
•5) Treatment within the previous 1 week (NSAIDs, steroid, herbal drug, acupuncture, etc.)
•6) participants who recieved Chuna manual therapy within the previous 2 week
•7) Women with (suspected) pregnancy or breast-feeding
•8) Participation in another clinical study within the previous 1 month
•9) Difculty in communicating with the investigators

发起方